Heritable Disorders of Connective Tissue Panel
ATTENTION: Effective August 27, 2024, this test is available for institutional billing and self-pay only. Insurance billing not accepted.
NY Approved
Test Overview
Clinical Utility
- Molecular confirmation of a clinical diagnosis in symptomatic individuals
- Risk assessment of asymptomatic family members of a proband diagnosed with a heritable connective tissue disorder
- Genetic counseling and recurrence risk determination
Test Details
Genes
ACTA2, ADAMTS2, AEBP1, ALDH18A1, ATP6V0A2, ATP6V1E1, ATP7A, B3GALT6, B3GAT3, B4GALT7, BGN, CBS, CHST14, COL11A1, COL11A2, COL12A1, COL1A1, COL1A2, COL2A1, COL3A1, COL4A1, COL5A1, COL5A2, COL9A1, COL9A2, COL9A3, DSE, EFEMP2, ELN, FBLN5, FBN1, FBN2, FKBP14, FLNA, LOX, LTBP4, MAT2A, MED12, MFAP5, MYH11, MYLK, NOTCH1, PLOD1, PRDM5, PRKG1, PYCR1, RIN2, SKI, SLC2A10, SLC39A13, SMAD2, SMAD3, SMAD4, TAB2, TGFB2, TGFB3, TGFBR1, TGFBR2, TNXB, ZNF469
Conditions
- Arterial Tortuosity syndrome
- Brittle Cornea syndrome
- Classical Ehlers-Danlos syndrome
- Congenital Contractural Arachnodactyly
- Cutis Laxa
- Ehlers-Danlos Syndrome
- Fibrochondrogenesis
- Homocystinuria due to Cystathionine Beta-Synthase Deficiency
- Loeys-Dietz syndrome (LDS)
- Marfan Syndrome/LDS/Related Disorders
- Marshall syndrome
- Multiple Epiphyseal Dysplasia (MED)
- Non-ocular stickler (STL3) / otospondylomegaepiphyseal dysplasia (OSMED)/ DFNA13/ DFNB53
- Occipital Horn Disease
- Shprintzen-Goldberg syndrome
- Spondyloepiphyseal dysplasia spectrum disorders
- Stickler syndrome
- Thoracic Aortic Aneurysm and Dissection (TAAD) and Related Disorders
- Vascular Ehlers-Danlos syndrome
- Weissenbach-Zweymuller syndrome
Lab Method
- Deletion/Duplication Analysis
- Next-Gen Sequencing
Ordering Information
Important Information
ATTENTION: Effective August 27, 2024, this test is available for institutional billing and self-pay only. Insurance billing not accepted.
Resources
Test Documents
Billing
Targeted Variant Testing